Microbiology 6- Prevention and treatment of viral diseases Flashcards

1
Q

Why was smallpox eradication successful (7)

A

No animal reservoir
No latent or persistent infection
Smallpox was an easily recognised disease
The vaccine was effective against all strains of virus
Vaccine properties. Potency, low cost, abundance, heat stability, easy administration
WHO determination
$250 million

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe live attenuated virus vaccines and give examples (10)

A

A natural virus with its genome inside the capsid which has had its virulence reduced so it only produces a mild infection and kick starts the immune response.

Examples:
Measles
Adenovius
Rotavirus
Rubella
Yellow fever

Influenza
smallpox

Mumps
Varicella
polio

(Marry is MVP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe inactivated virus vaccines and give examples (5)

A

You take the parental virus and treat it with chemicals and heat to destroy the genome so it is no longer infectious
However, if injected into a person, the viral proteins will still be recognised and an immune response will be triggered

Examples
Hep A
Japanese encephalitis
Polio
Rabies
Tick-borne encephaliti
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Purified subunit vaccine

A

Original parental genome has been taken and treated with proteases to chop it into little pieces

These are subunits of the virus which contains antigens that can trigger an immune response

Example
Influenza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cloning

A

3 types
virus vector vaccine,
DNA vaccine,
Virus-like particle vaccine

Parts of the original viral genome are cloned inside bacteria

You can put the DNA into virus-like particles (e.g. HPV vaccine)

You may just inject viral DNA into people

You may make a new virus which doesn’t make people ill but has a segment of virulent material from the original virus

examples
hep b
HPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the attenuation of Viruses to make Live Virus Vaccines (5)

A

Isolate pathogenic virus from patient

Grow in human cells

Take cultured virus and infect monkey cells

Gradually the genome of the virus will adapt to the monkey cells and it will become a monkey virus

The virus will no longer grow well in human cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pros(3) and cons(2) of live vaccine

A

Rapid broad, long lived immunity
Dose sparing
Cellular immunity

BUT
Requires attenuation
May revert

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pros(2) and cons (2) of inactivated vaccine

A

Safe
Can be made from wild type virus

BUT
Frequent boosting required
High doses needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain the two types of vaccine used agasint influenza

A

Inactivated vaccine or the subunit vaccine consists only of the spike proteins (HA)
Given to people are risk - e.g. over 65, asthmatics, diabetes, CVD
Also given to healthcare workers
IT DOES NOT GIVE YOU FLU

Live Attenuated Influenza Vaccine

Cold Adapted - can replicate at 32 degrees (nose) but not at 37 degrees

Given as a nasal spray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain the two types of vaccine used agasint Polio

A

SALK inactivated vaccine
Preparation of virus which has been treated so it can no longer replicate
Isn’t a particularly good vaccine - need a large dose

SABINE live attenuated vaccine
This is better
1 in 7 million vaccinations result in poliomyelitis
If this vaccine was given to people who are immunosuppressed they get a PERSISTING INFECTION - they are reservoirs of live polio virus

We must stop using Sabine and switch to Salk for the end game

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Making recombinant attenuated virus vaccines

A

Pathogenic virus genome typically consists of receptor-binding gene, virulence gene and capsid protein genes

You can either mutate the virulence gene or delete the virulence gene

You then get a virus which is IMMUNOGENIC but NOT VIRULENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can happen after the shingles infection has gone

A

pain could remain as Post Herpetic Neuralgia (PHN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are interferons and what are some problems with them

A

switch on a natural antiviral response

Problem with Interferons: switches on everything including inflammation and fever

By giving interferons - you would suppress the virus but you would make the patient feel even worse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is acyclovir, what does it do and why does it only affect viral cells?

A

Chain Terminator

The modified nucleosides are incorporated into the DNA

Lack of a 3’ hydroxyl group (the part which the next nucleotide usually attaches onto) means that the chain terminates and a phosphodiester bond isn’t formed

You administer it as the pro-drug and it can only be phosphorylated by virus encoded enzyme - THYMIDINE KINASE

Furthermore, acyclovir has a higher affinity for Viral DNA polymerase than host DNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the action of neuraminidase inhibitors

A

virus produces neuraminidase which moves to the cell surface and destroys sialic acid so the virus can leave

We can make neuraminidase inhibitors which are substrate analgoues that can sit in the pocket and act as inhibitors stopping neuraminidase binding

Examples
Relenza
Tamiflu

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

5 groups of HIV drugs

A

NRTI (Nucleoside Reverse Transcriptase Inhibitor)

NNRTI (Non-Nucleoside Reverse Transcriptase Inhibitor) -Binds enzymes but not at the active site

Integrase Inhibitor

Entry Inhibitors

Protease Inhibitors

17
Q

Treatments for Hep c

A

Protease Inhibitor - asunaprevir

NS5A inhibitor - daclastivir

NS3-4A inhibitor- telaprivir and boceprivir

18
Q

Treatments for ebola

A

zmapp- 3 monoclonal antibodies